JUNE 4, 2026 AT 02:02 PM

US Supreme Court has ruled in favour of Hikma (HIK LN) in 'skinny label' patent dispute over Amarin heart drug Vascepa

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

Open Dashboard

#UNITED KINGDOM#EUROPE#AMARIN CORP PLC#HIKMA PHARMACEUTICALS PLC#HIK.LN#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#FTSE 100 INDEX#HIK#FTSE 100#EUROPEAN EQUITIES